No Data Yet
Markets saw a surge in speculative trading, concentrated in micro-cap biotechs and Special Purpose Acquisition Companies (SPACs). This activity, driven by company-specific catalysts and broad risk appetite, occurred alongside significant moves in established firms reacting to fundamental news.